Literature DB >> 10519867

Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group.

G Defazio1, A Berardelli, G Abbruzzese, V Coviello, F Carella, M T De Berardinis, G Galardi, P Girlanda, S Maurri, M Mucchiut, A Albanese, M Basciani, L Bertolasi, R Liguori, N Tambasco, L Santoro, G Assennato, P Livrea.   

Abstract

OBJECTIVES: Little is known about factors influencing the spread of blepharospasm to other body parts. An investigation was carried out to deterrmine whether demographic features (sex, age at blepharospasm onset), putative risk, or protective factors for blepharospasm (family history of dystonia or tremor, previous head or face trauma with loss of consciousness, ocular diseases, and cigarette smoking), age related diseases (diabetes, hypertension), edentulousness, and neck or trunk trauma preceding the onset of blepharospasm could distinguish patients with blepharospasm who had spread of dystonia from those who did not.
METHODS: 159 outpatients presenting initially with blepharospasm were selected in 16 Italian Institutions. There were 104 patients with focal blepharospasm (mean duration of disease 5.3 (SD 1.9) years) and 55 patients in whom segmental or multifocal dystonia developed (mainly in the cranial cervical area) 1.5 (1.2) years after the onset of blepharospasm. Information was obtained from a standardised questionnaire administered by medical interviewers. A Cox regression model was used to examine the relation between the investigated variables and spread.
RESULTS: Previous head or face trauma with loss of consciousness, age at the onset of blepharospasm, and female sex were independently associated with an increased risk of spread. A significant association was not found between spread of dystonia and previous ocular diseases, hypertension, diabetes, neck or trunk trauma, edentulousness, cigarette smoking, and family history of dystonia or tremor. An unsatisfactory study power negatively influenced the validity and accuracy of the negative findings relative to diabetes, neck or trunk trauma, and cigarette smoking.
CONCLUSIONS: The results of this exploratory study confirm that patients presenting initially with blepharospasm are most likely to experience some spread of dystonia within a few years of the onset of blepharospasm and suggest that head or face trauma with loss of consciousness preceding the onset, age at onset, and female sex may be relevant to spread. The suggested association between edentulousness and cranial cervical dystonia may be apparent because of the confounding effect of both age at onset and head or face trauma with loss of consciousness. The lack of influence of family history of dystonia on spread is consistent with previous findings indicating that the inheritance pattern is the same for focal and segmental blepharospasm.

Entities:  

Mesh:

Year:  1999        PMID: 10519867      PMCID: PMC1736622          DOI: 10.1136/jnnp.67.5.613

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

Review 1.  Secondary dystonia.

Authors:  D B Calne; A E Lang
Journal:  Adv Neurol       Date:  1988

Review 2.  Ophthalmologic causes of blepharospasm.

Authors:  D Pita Salorio; R Quintana Conte
Journal:  Adv Neurol       Date:  1988

3.  Psychogenic dystonia.

Authors:  S Fahn; D T Williams
Journal:  Adv Neurol       Date:  1988

4.  Orofacial dyskinesia. A dental dimension.

Authors:  H D Sutcher; R B Underwood; R A Beatty; O Sugar
Journal:  JAMA       Date:  1971-05-31       Impact factor: 56.272

5.  MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia.

Authors:  J S Perlmutter; L W Tempel; K J Black; D Parkinson; R D Todd
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group.

Authors:  G Defazio; A Berardelli; G Abbruzzese; V Lepore; V Coviello; D Acquistapace; L Capus; F Carella; M T De Berardinis; G Galardi; P Girlanda; S Maurri; A Albanese; L Bertolasi; R Liguori; A Rossi; L Santoro; G Tognoni; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

7.  Sex prevalence of focal dystonias.

Authors:  V L Soland; K P Bhatia; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

8.  Spread of symptoms in idiopathic torsion dystonia.

Authors:  P Greene; U J Kang; S Fahn
Journal:  Mov Disord       Date:  1995-03       Impact factor: 10.338

9.  Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: a multicenter study.

Authors:  G Defazio; V Lepore; G Abbruzzese; E Barontini; A Berardelli; T Caraceni; F Carella; P Girlanda; M Manfredi; C Messina
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

10.  Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients.

Authors:  J Jankovic; J Ford
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  17 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

Review 2.  Botulinum toxin in the management of blepharospasm: current evidence and recent developments.

Authors:  Amy Hellman; Diego Torres-Russotto
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

4.  Diffusion tensor imaging in blepharospasm and blepharospasm-oromandibular dystonia.

Authors:  Jing Yang; ChunYan Luo; Wei Song; XiaoYan Guo; Bi Zhao; XuePing Chen; XiaoQi Huang; QiYong Gong; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-05-03       Impact factor: 4.849

5.  Head trauma in primary cranial dystonias: a multicentre case-control study.

Authors:  Davide Martino; Giovanni Defazio; Giovanni Abbruzzese; Paolo Girlanda; Michele Tinazzi; Giovanni Fabbrini; Maria Stella Aniello; Laura Avanzino; Carlo Colosimo; Giovanni Majorana; Giuseppe Majorana; Carlo Trompetto; Alfredo Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

6.  Spread of primary dystonia in relation to initially affected region.

Authors:  Marina Svetel; Tanja Pekmezović; Jasmina Jović; Natasa Ivanović; Natasa Dragasević; Jelena Marić; Vladimir S Kostić
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

7.  A family study on primary blepharospasm.

Authors:  G Defazio; D Martino; M S Aniello; G Masi; G Abbruzzese; S Lamberti; E M Valente; F Brancati; P Livrea; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

8.  Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Authors:  Scott A Norris; H A Jinnah; Alberto J Espay; Christine Klein; Norbert Brüggemann; Richard L Barbano; Irene Andonia C Malaty; Ramon L Rodriguez; Marie Vidailhet; Emmanuel Roze; Stephen G Reich; Brian D Berman; Mark S LeDoux; Sarah Pirio Richardson; Pinky Agarwal; Zoltan Mari; William G Ondo; Ludy C Shih; Susan H Fox; Alfredo Berardelli; Claudia M Testa; Florence Ching-Fen Cheng; Daniel Truong; Fatta B Nahab; Tao Xie; Mark Hallett; Ami R Rosen; Laura J Wright; Joel S Perlmutter
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

Review 9.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm.

Authors:  Giovanni Defazio; Mar Matarin; Elizabeth L Peckham; Davide Martino; Enza M Valente; Andrew Singleton; Anthony Crawley; Maria Stella Aniello; Francesco Brancati; Giovanni Abbruzzese; Paolo Girlanda; Paolo Livrea; Mark Hallett; Alfredo Berardelli
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.